Abstract:Abstract: Objective?To summarize the experience of retrograde intrarenal surgery (RIRS) technology in treatment of upper urinary calculi for ten years, and evaluate its safety and clinical efficacy.?Methods?From June 2007 to June 2017, we used RIRS to treat 10,413 patients with upper urinary calculi. 774 cases were treated by removable flexible ureteroscopy, 2293 cases by double-channel flexible ureteroscopy, and 7346 cases by electronic flexible ureteroscopy. Success rate, stone clearance rate, operation time, surgical complications, and length of hospital stay were analyzed respectively.?Results?The success rate of the first-stage operation of the three surgical methods was 73.00%, 82.99%, and 91.00%, respectively. The second-stage operation (first stage placement of the D-J stent) was 27.00%, 17.01% and 9.00% . respectively. The average stone free rate was 87.00%, 89.00% and 93.00%, respectively. The average operation time was (112.0?±?32.5), (90.0?±?24.0) and (75.5?±?20.5) min, respectively. The average hospitalization time was (9.0?±?1.5), (7.0?±?1.0) and (5.0?±?1.5) days, respectively. The surgical complication rate was 3.62%, 1.30% and 1.00%, respectively.?Conclusion?RIRS technology is safe, effective and reliable treatment for the upper urinary calculi. The continuous improvement and innovation of relative technology, as well as the continuous optimization of ureteroscope-related equipment, have improved the surgical success rate and stone removal rate. The data of complications and hospitalization days have been continuously reduced. It is foreseeable that the clinical indications for this technology will gradually expand.